Literature DB >> 25970436

Interplay of Immune Cells in Mooren Ulcer.

Hyun Ju Lee1, Mee Kum Kim, Won Ryang Wee, Joo Youn Oh.   

Abstract

PURPOSE: To report the histopathological findings of the cornea with fulminant Mooren ulcer, an idiopathic autoimmune keratitis.
METHODS: A 54-year-old woman was diagnosed with Mooren ulcer. Despite intensive immunosuppression, corneal perforation developed, and penetrating keratoplasty with a limbal tectonic graft was performed. The removed cornea was histopathologically evaluated for the phenotype of the cells infiltrating the lesion.
RESULTS: Hematoxylin-eosin staining showed massive infiltration of inflammatory cells in the anterior corneal stroma and epithelial hyperplasia in the adjacent conjunctiva. Further analysis with immunohistochemistry indicated that the cells infiltrating the lesion included a number of CD4⁺ and CD8⁺ T lymphocytes, CD19CD45⁺ B lymphocytes, and CD14CD68⁺ macrophages. There were a few neutrophils and no CD56⁺ NK cells.
CONCLUSIONS: Our findings suggest that multiple types of immune cells including T cells, B cells, and macrophages are involved in the pathogenesis of Mooren ulcer.

Entities:  

Mesh:

Year:  2015        PMID: 25970436     DOI: 10.1097/ICO.0000000000000471

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  3 in total

1.  Upregulation of NLRP3 inflammasome components in Mooren's ulcer.

Authors:  Zhiyuan Li; Chao Wei; Shuang Wang; Ting Liu; Hualei Zhai; Weiyun Shi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-28       Impact factor: 3.117

2.  Increased succinate receptor GPR91 involved in the pathogenesis of Mooren's ulcer.

Authors:  Lin Li; Yan-Ling Dong; Ting Liu; Dan Luo; Chao Wei; Wei-Yun Shi
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

3.  Large-diameter Deep Anterior Lamel-lar Keratoplasty: An Alternative Treatment for Mooren Ulcer.

Authors:  Yang Kyung Cho; Sun Young Lee; Ui Ju Cho; Balamurali K Ambati
Journal:  Korean J Ophthalmol       Date:  2020-10-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.